The Court of Arbitration for Sport (CAS) has issued its decision in the human anti-doping case concerning Eric Lamaze. 

A press update from FEI reads: 

"On 8 March 2022, Mr Lamaze had received a formal notice of disciplinary charge by the FEI, for commission of an anti-doping rule violation in accordance with article 2.3 Evading, Refusing or Failing to Submit to Sample Collection by an Athlete, of the FEI Anti-Doping Rules for Human Athletes (ADRHA), at CSI5* - GCT/GCL - Valkenswaard (NED), 4-6 June 2021.

While CAS proceedings were ongoing, Mr Lamaze submitted forged medical documents, which led to a four-year ineligibility period imposed by the FEI and starting on 12 September 2023.

In its decision, the CAS Panel found Mr Lamaze guilty of the anti-doping rule violation and imposed an ineligibility period of four years, starting once the ineligibility period already imposed by the FEI has ended. The additional four-year suspension imposed by CAS will start on 12 September 2027 and end on 11 September 2031. Furthermore, Mr Lamaze was fined CHF 15,000, was ordered to pay the costs of the arbitration proceedings as well as CHF 12,000 to the FEI as a contribution towards the legal fees. The results obtained at the event, along with all results obtained by the athlete at FEI Events from 5 June 2021 to 30 March 2022, are disqualified."